Molecular diagnostics and testing
These services match molecular elements of an individual patient’s disease to drugs able to affect those elements.
Source: LinkedIn company description · Retrieved November 17, 2026

Monogram Biosciences develops and commercializes products intended to guide treatment of infectious diseases, cancer, and other serious diseases.
Its molecular diagnostics and testing services enable healthcare providers to optimize patients’ treatment regimens. The company works with pharmaceutical companies on antiviral therapeutics, vaccines, and targeted cancer therapeutics.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
These services match molecular elements of an individual patient’s disease to drugs able to affect those elements.
Source: LinkedIn company description · Retrieved November 17, 2026
The company has developed assays intended to make antiretroviral therapy easier to manage.
Source: LinkedIn company description · Retrieved November 17, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on November 17, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 18, 2026. Directory positions use company-contact counts from separate saved list snapshots dated October 26, 2026, November 4, 2026, November 5, 2026 and November 6, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.